Innovative Beneish M Score

IMTH -  USA Stock  

USD 0.28  0.00  0.00%

This module uses fundamental data of Innovative Medtech to approximate the value of its Beneish M Score. Innovative Medtech M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Please see Innovative Medtech Piotroski F Score and Innovative Medtech Altman Z Score analysis.

Innovative Beneish M Score 

 
Refresh
At this time, Innovative Medtech's M Score is unavailable. The earnings manipulation may begin if Innovative Medtech's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Innovative Medtech executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Innovative Medtech's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Unavailable
Elasticity of Receivables
N/A
Asset Quality
N/A
Expense Coverage
N/A
Gross Margin Strengs
N/A
Accruals Factor
N/A
Depreciation Resistance
N/A
Net Sales Growth
N/A
Financial Leverage Condition
N/A

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

About Innovative Medtech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Innovative Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovative Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovative Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Innovative MedTech Inc., through its subsidiaries, provides health and wellness services in the United States. Innovative MedTech Inc. was incorporated in 2005 and is based in Blue Island, Illinois. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 37 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Innovative Medtech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Innovative Medtech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Innovative Medtech Piotroski F Score and Innovative Medtech Altman Z Score analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Innovative Medtech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innovative Medtech. If investors know Innovative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innovative Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.